A patent currently prevents the manufacturing of any generic versions of INCIVEK (telaprevir) at this time. This patent is scheduled to expire in February 2025, which would be the earliest date that a generic version could become available. However, lawsuits or other patents for new uses of the drug may delay the manufacturing of a generic INCIVEK.
Can I Buy Generic INCIVEK?INCIVEK® (telaprevir) is a prescription medication approved for treating chronic hepatitis C in combination with other medications. It belongs to a group of medications called protease inhibitors.
INCIVEK is made by Vertex Pharmaceuticals Incorporated. Currently, the drug is protected by exclusivity rights that prevent any generic versions from being sold in the United States.
When Will a Generic Version Be Available?The first patent for INCIVEK is set to expire in February 2025. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for INCIVEK uses. Once the patent expires, there may be several companies that manufacture a generic INCIVEK drug.
Is Telaprevir a Generic Form of INCIVEK?No -- telaprevir is the active ingredient in INCIVEK, but it is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name." The generic name is different from a generic version of a medicine.
In order for there to be a generic version of a medicine, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.